SCHEMBL14466751

SCHEMBL14466751

NOc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4ccccn4)cc3)NC(=O)NC1=O)C2

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6005070 0.92 ADAM17 (1.00) ADAM17
SCHEMBL7906097 0.87 ADAM17 (0.77) ADAM17
SCHEMBL14466482 0.85 ADAM17 (0.63) ADAM17
SCHEMBL17570701 0.85 ADAM17 (0.84) ADAM17
SCHEMBL8227325 0.84 ADAM17 (0.85) ADAM17
SCHEMBL17570711 0.83 ADAM17 (0.84) ADAM17
SCHEMBL18699718 0.83 ADAM17 (0.70) ADAM17
SCHEMBL17570599 0.83 ADAM17 (0.85) ADAM17
SCHEMBL14467188 0.83 ADAM17 (0.60) ADAM17
SCHEMBL12860490 0.82 ADAM17 (0.82) ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007084415-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2007-07-26 WO disclosed